Medication adherence in type 2 diabetes: the ENTRED study 2007, a French Population-Based Study

Adherence to prescribed medications is a key dimension of healthcare quality. The aim of this large population-based study was to evaluate self-reported medication adherence and to identify factors linked with poor adherence in patients with type 2 diabetes in France. The ENTRED study 2007, a French...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2012-03, Vol.7 (3), p.e32412-e32412
Hauptverfasser: Tiv, Michel, Viel, Jean-François, Mauny, Frédéric, Eschwège, Eveline, Weill, Alain, Fournier, Cécile, Fagot-Campagna, Anne, Penfornis, Alfred
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e32412
container_issue 3
container_start_page e32412
container_title PloS one
container_volume 7
creator Tiv, Michel
Viel, Jean-François
Mauny, Frédéric
Eschwège, Eveline
Weill, Alain
Fournier, Cécile
Fagot-Campagna, Anne
Penfornis, Alfred
description Adherence to prescribed medications is a key dimension of healthcare quality. The aim of this large population-based study was to evaluate self-reported medication adherence and to identify factors linked with poor adherence in patients with type 2 diabetes in France. The ENTRED study 2007, a French national survey of people treated for diabetes, was based on a representative sample of patients who claimed reimbursement for oral hypoglycaemic agents and/or insulin at least three times between August 2006 and July 2007, and who were randomly selected from the database of the two main National Health Insurance Systems. Medication adherence was determined using a six-item self-administered questionnaire. A multinomial polychotomous logistic regression model was used to identify factors associated with medication adherence in the 3,637 persons with type 2 diabetes. Thirty nine percent of patients reported good medication adherence, 49% medium adherence and 12% poor adherence. The factors significantly associated with poor adherence in multivariate analysis were socio-demographic factors: age 8% and existing diabetes complications; and health care-related factors: difficulties for taking medication alone, decision making by the patient only, poor acceptability of medical recommendations, lack of family or social support, need for information on treatment, reporting no confidence in the future, need for medical support and follow-up by a specialist physician. In a country with a high level of access to healthcare, our study demonstrated a substantial low level of medication adherence in type 2 diabetic patients. Better identification of those with poor adherence and individualised suitable recommendations remain essential for better healthcare management.
doi_str_mv 10.1371/journal.pone.0032412
format Article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1323964555</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A477157209</galeid><doaj_id>oai_doaj_org_article_6e2c5ca4c7ba4d69af3990a26d3177d3</doaj_id><sourcerecordid>A477157209</sourcerecordid><originalsourceid>FETCH-LOGICAL-c791t-c059738a713056fc49f4b4a5018fa3c6b68f00d15dbefb4e012241dddd655aed3</originalsourceid><addsrcrecordid>eNqNk11v0zAUhiMEYmPwDxBYmgSaRIs_YrvmAqmMjlUqDG2DW8uxT5pUaVziZKL_HmftpnbaBfaFrePnfW0f-yTJa4KHhEnyceG7pjbVcOVrGGLMaErok-SQKEYHgmL2dGd-kLwIYYExZyMhnicHlKaYCZ4eJvo7uNKatvQ1Mq6ABmoLqKxRu14BosiVJoMWwifUFoAmP64vJ19RaDu3RhRj-QEZdNZrCvTTr7rq1mjwxQRw6KqnXibPclMFeLUdj5JfZ5Pr0_PB7OLb9HQ8G1ipSDuwmCvJRkYShrnIbaryNEsNx2SUG2ZFJkY5xo5wl0GepYBJvAJxsQnODTh2lLzd-K4qH_Q2N0ETRpkSKec8EtMN4bxZ6FVTLk2z1t6U-jbgm7k2TVvaCrQAark1qZWZSZ1QJmdKYUOFY0RKx6LX5-1uXbYEZ6FuG1Ptme6v1GWh5_5GM6qYVCIanGwMigey8_FM9zGMR5QxxW5IZN9vN2v8nw5Cq5dlsFBVpgbfBa2oFIoy3LsePyAfT8SWmpt417LOfTyi7T31OJWScEmxitTwESp2B8vSxj-XlzG-JzjZE0Smhb_t3HQh6OnV5f-zF7_32Xc7bAGmaovgq67_aWEfTDegbXwIDeT3iSVY9yVzlw3dl4zelkyUvdl9y3vRXY2wf_TrDZ8</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1323964555</pqid></control><display><type>article</type><title>Medication adherence in type 2 diabetes: the ENTRED study 2007, a French Population-Based Study</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><source>Public Library of Science (PLoS)</source><creator>Tiv, Michel ; Viel, Jean-François ; Mauny, Frédéric ; Eschwège, Eveline ; Weill, Alain ; Fournier, Cécile ; Fagot-Campagna, Anne ; Penfornis, Alfred</creator><creatorcontrib>Tiv, Michel ; Viel, Jean-François ; Mauny, Frédéric ; Eschwège, Eveline ; Weill, Alain ; Fournier, Cécile ; Fagot-Campagna, Anne ; Penfornis, Alfred</creatorcontrib><description>Adherence to prescribed medications is a key dimension of healthcare quality. The aim of this large population-based study was to evaluate self-reported medication adherence and to identify factors linked with poor adherence in patients with type 2 diabetes in France. The ENTRED study 2007, a French national survey of people treated for diabetes, was based on a representative sample of patients who claimed reimbursement for oral hypoglycaemic agents and/or insulin at least three times between August 2006 and July 2007, and who were randomly selected from the database of the two main National Health Insurance Systems. Medication adherence was determined using a six-item self-administered questionnaire. A multinomial polychotomous logistic regression model was used to identify factors associated with medication adherence in the 3,637 persons with type 2 diabetes. Thirty nine percent of patients reported good medication adherence, 49% medium adherence and 12% poor adherence. The factors significantly associated with poor adherence in multivariate analysis were socio-demographic factors: age &lt;45 years, non-European geographical origin, financial difficulties and being professionally active; disease and therapy-related factors: HbA(1c)&gt;8% and existing diabetes complications; and health care-related factors: difficulties for taking medication alone, decision making by the patient only, poor acceptability of medical recommendations, lack of family or social support, need for information on treatment, reporting no confidence in the future, need for medical support and follow-up by a specialist physician. In a country with a high level of access to healthcare, our study demonstrated a substantial low level of medication adherence in type 2 diabetic patients. Better identification of those with poor adherence and individualised suitable recommendations remain essential for better healthcare management.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0032412</identifier><identifier>PMID: 22403654</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Adhesion ; Adolescent ; Adult ; Aged ; Aged, 80 and over ; Analysis ; Complications ; Decision making ; Demographics ; Diabetes ; Diabetes mellitus ; Diabetes Mellitus, Type 2 - drug therapy ; Diabetics ; Drug therapy ; Drugs ; Education ; Female ; France ; Health care ; Health insurance ; Health surveys ; Hospitals ; Humans ; Hypertension ; Insulin ; Life Sciences ; Low level ; Male ; Medical care quality ; Medical research ; Medication adherence ; Medication Adherence - statistics &amp; numerical data ; Medicine ; Metabolism ; Middle Aged ; Mortality ; Multivariate Analysis ; National health insurance ; Patient compliance ; Patients ; Population studies ; Population-based studies ; Questionnaires ; Regression analysis ; Regression models ; Response rates ; Risk Factors ; Santé publique et épidémiologie ; Self Report ; Skill development ; Social aspects ; Social interactions ; Studies ; Substance abuse treatment ; Surveys ; Type 2 diabetes ; Young Adult</subject><ispartof>PloS one, 2012-03, Vol.7 (3), p.e32412-e32412</ispartof><rights>COPYRIGHT 2012 Public Library of Science</rights><rights>2012 Tiv et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><rights>Tiv et al. 2012</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c791t-c059738a713056fc49f4b4a5018fa3c6b68f00d15dbefb4e012241dddd655aed3</citedby><cites>FETCH-LOGICAL-c791t-c059738a713056fc49f4b4a5018fa3c6b68f00d15dbefb4e012241dddd655aed3</cites><orcidid>0000-0002-6716-7468</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3293796/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3293796/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,2096,2915,23845,27901,27902,53766,53768,79343,79344</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22403654$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-00823393$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Tiv, Michel</creatorcontrib><creatorcontrib>Viel, Jean-François</creatorcontrib><creatorcontrib>Mauny, Frédéric</creatorcontrib><creatorcontrib>Eschwège, Eveline</creatorcontrib><creatorcontrib>Weill, Alain</creatorcontrib><creatorcontrib>Fournier, Cécile</creatorcontrib><creatorcontrib>Fagot-Campagna, Anne</creatorcontrib><creatorcontrib>Penfornis, Alfred</creatorcontrib><title>Medication adherence in type 2 diabetes: the ENTRED study 2007, a French Population-Based Study</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Adherence to prescribed medications is a key dimension of healthcare quality. The aim of this large population-based study was to evaluate self-reported medication adherence and to identify factors linked with poor adherence in patients with type 2 diabetes in France. The ENTRED study 2007, a French national survey of people treated for diabetes, was based on a representative sample of patients who claimed reimbursement for oral hypoglycaemic agents and/or insulin at least three times between August 2006 and July 2007, and who were randomly selected from the database of the two main National Health Insurance Systems. Medication adherence was determined using a six-item self-administered questionnaire. A multinomial polychotomous logistic regression model was used to identify factors associated with medication adherence in the 3,637 persons with type 2 diabetes. Thirty nine percent of patients reported good medication adherence, 49% medium adherence and 12% poor adherence. The factors significantly associated with poor adherence in multivariate analysis were socio-demographic factors: age &lt;45 years, non-European geographical origin, financial difficulties and being professionally active; disease and therapy-related factors: HbA(1c)&gt;8% and existing diabetes complications; and health care-related factors: difficulties for taking medication alone, decision making by the patient only, poor acceptability of medical recommendations, lack of family or social support, need for information on treatment, reporting no confidence in the future, need for medical support and follow-up by a specialist physician. In a country with a high level of access to healthcare, our study demonstrated a substantial low level of medication adherence in type 2 diabetic patients. Better identification of those with poor adherence and individualised suitable recommendations remain essential for better healthcare management.</description><subject>Adhesion</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Analysis</subject><subject>Complications</subject><subject>Decision making</subject><subject>Demographics</subject><subject>Diabetes</subject><subject>Diabetes mellitus</subject><subject>Diabetes Mellitus, Type 2 - drug therapy</subject><subject>Diabetics</subject><subject>Drug therapy</subject><subject>Drugs</subject><subject>Education</subject><subject>Female</subject><subject>France</subject><subject>Health care</subject><subject>Health insurance</subject><subject>Health surveys</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Insulin</subject><subject>Life Sciences</subject><subject>Low level</subject><subject>Male</subject><subject>Medical care quality</subject><subject>Medical research</subject><subject>Medication adherence</subject><subject>Medication Adherence - statistics &amp; numerical data</subject><subject>Medicine</subject><subject>Metabolism</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Multivariate Analysis</subject><subject>National health insurance</subject><subject>Patient compliance</subject><subject>Patients</subject><subject>Population studies</subject><subject>Population-based studies</subject><subject>Questionnaires</subject><subject>Regression analysis</subject><subject>Regression models</subject><subject>Response rates</subject><subject>Risk Factors</subject><subject>Santé publique et épidémiologie</subject><subject>Self Report</subject><subject>Skill development</subject><subject>Social aspects</subject><subject>Social interactions</subject><subject>Studies</subject><subject>Substance abuse treatment</subject><subject>Surveys</subject><subject>Type 2 diabetes</subject><subject>Young Adult</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><sourceid>DOA</sourceid><recordid>eNqNk11v0zAUhiMEYmPwDxBYmgSaRIs_YrvmAqmMjlUqDG2DW8uxT5pUaVziZKL_HmftpnbaBfaFrePnfW0f-yTJa4KHhEnyceG7pjbVcOVrGGLMaErok-SQKEYHgmL2dGd-kLwIYYExZyMhnicHlKaYCZ4eJvo7uNKatvQ1Mq6ABmoLqKxRu14BosiVJoMWwifUFoAmP64vJ19RaDu3RhRj-QEZdNZrCvTTr7rq1mjwxQRw6KqnXibPclMFeLUdj5JfZ5Pr0_PB7OLb9HQ8G1ipSDuwmCvJRkYShrnIbaryNEsNx2SUG2ZFJkY5xo5wl0GepYBJvAJxsQnODTh2lLzd-K4qH_Q2N0ETRpkSKec8EtMN4bxZ6FVTLk2z1t6U-jbgm7k2TVvaCrQAark1qZWZSZ1QJmdKYUOFY0RKx6LX5-1uXbYEZ6FuG1Ptme6v1GWh5_5GM6qYVCIanGwMigey8_FM9zGMR5QxxW5IZN9vN2v8nw5Cq5dlsFBVpgbfBa2oFIoy3LsePyAfT8SWmpt417LOfTyi7T31OJWScEmxitTwESp2B8vSxj-XlzG-JzjZE0Smhb_t3HQh6OnV5f-zF7_32Xc7bAGmaovgq67_aWEfTDegbXwIDeT3iSVY9yVzlw3dl4zelkyUvdl9y3vRXY2wf_TrDZ8</recordid><startdate>20120305</startdate><enddate>20120305</enddate><creator>Tiv, Michel</creator><creator>Viel, Jean-François</creator><creator>Mauny, Frédéric</creator><creator>Eschwège, Eveline</creator><creator>Weill, Alain</creator><creator>Fournier, Cécile</creator><creator>Fagot-Campagna, Anne</creator><creator>Penfornis, Alfred</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>1XC</scope><scope>VOOES</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-6716-7468</orcidid></search><sort><creationdate>20120305</creationdate><title>Medication adherence in type 2 diabetes: the ENTRED study 2007, a French Population-Based Study</title><author>Tiv, Michel ; Viel, Jean-François ; Mauny, Frédéric ; Eschwège, Eveline ; Weill, Alain ; Fournier, Cécile ; Fagot-Campagna, Anne ; Penfornis, Alfred</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c791t-c059738a713056fc49f4b4a5018fa3c6b68f00d15dbefb4e012241dddd655aed3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adhesion</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Analysis</topic><topic>Complications</topic><topic>Decision making</topic><topic>Demographics</topic><topic>Diabetes</topic><topic>Diabetes mellitus</topic><topic>Diabetes Mellitus, Type 2 - drug therapy</topic><topic>Diabetics</topic><topic>Drug therapy</topic><topic>Drugs</topic><topic>Education</topic><topic>Female</topic><topic>France</topic><topic>Health care</topic><topic>Health insurance</topic><topic>Health surveys</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Insulin</topic><topic>Life Sciences</topic><topic>Low level</topic><topic>Male</topic><topic>Medical care quality</topic><topic>Medical research</topic><topic>Medication adherence</topic><topic>Medication Adherence - statistics &amp; numerical data</topic><topic>Medicine</topic><topic>Metabolism</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Multivariate Analysis</topic><topic>National health insurance</topic><topic>Patient compliance</topic><topic>Patients</topic><topic>Population studies</topic><topic>Population-based studies</topic><topic>Questionnaires</topic><topic>Regression analysis</topic><topic>Regression models</topic><topic>Response rates</topic><topic>Risk Factors</topic><topic>Santé publique et épidémiologie</topic><topic>Self Report</topic><topic>Skill development</topic><topic>Social aspects</topic><topic>Social interactions</topic><topic>Studies</topic><topic>Substance abuse treatment</topic><topic>Surveys</topic><topic>Type 2 diabetes</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tiv, Michel</creatorcontrib><creatorcontrib>Viel, Jean-François</creatorcontrib><creatorcontrib>Mauny, Frédéric</creatorcontrib><creatorcontrib>Eschwège, Eveline</creatorcontrib><creatorcontrib>Weill, Alain</creatorcontrib><creatorcontrib>Fournier, Cécile</creatorcontrib><creatorcontrib>Fagot-Campagna, Anne</creatorcontrib><creatorcontrib>Penfornis, Alfred</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tiv, Michel</au><au>Viel, Jean-François</au><au>Mauny, Frédéric</au><au>Eschwège, Eveline</au><au>Weill, Alain</au><au>Fournier, Cécile</au><au>Fagot-Campagna, Anne</au><au>Penfornis, Alfred</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Medication adherence in type 2 diabetes: the ENTRED study 2007, a French Population-Based Study</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2012-03-05</date><risdate>2012</risdate><volume>7</volume><issue>3</issue><spage>e32412</spage><epage>e32412</epage><pages>e32412-e32412</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Adherence to prescribed medications is a key dimension of healthcare quality. The aim of this large population-based study was to evaluate self-reported medication adherence and to identify factors linked with poor adherence in patients with type 2 diabetes in France. The ENTRED study 2007, a French national survey of people treated for diabetes, was based on a representative sample of patients who claimed reimbursement for oral hypoglycaemic agents and/or insulin at least three times between August 2006 and July 2007, and who were randomly selected from the database of the two main National Health Insurance Systems. Medication adherence was determined using a six-item self-administered questionnaire. A multinomial polychotomous logistic regression model was used to identify factors associated with medication adherence in the 3,637 persons with type 2 diabetes. Thirty nine percent of patients reported good medication adherence, 49% medium adherence and 12% poor adherence. The factors significantly associated with poor adherence in multivariate analysis were socio-demographic factors: age &lt;45 years, non-European geographical origin, financial difficulties and being professionally active; disease and therapy-related factors: HbA(1c)&gt;8% and existing diabetes complications; and health care-related factors: difficulties for taking medication alone, decision making by the patient only, poor acceptability of medical recommendations, lack of family or social support, need for information on treatment, reporting no confidence in the future, need for medical support and follow-up by a specialist physician. In a country with a high level of access to healthcare, our study demonstrated a substantial low level of medication adherence in type 2 diabetic patients. Better identification of those with poor adherence and individualised suitable recommendations remain essential for better healthcare management.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>22403654</pmid><doi>10.1371/journal.pone.0032412</doi><tpages>e32412</tpages><orcidid>https://orcid.org/0000-0002-6716-7468</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2012-03, Vol.7 (3), p.e32412-e32412
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_1323964555
source MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Free Full-Text Journals in Chemistry; Public Library of Science (PLoS)
subjects Adhesion
Adolescent
Adult
Aged
Aged, 80 and over
Analysis
Complications
Decision making
Demographics
Diabetes
Diabetes mellitus
Diabetes Mellitus, Type 2 - drug therapy
Diabetics
Drug therapy
Drugs
Education
Female
France
Health care
Health insurance
Health surveys
Hospitals
Humans
Hypertension
Insulin
Life Sciences
Low level
Male
Medical care quality
Medical research
Medication adherence
Medication Adherence - statistics & numerical data
Medicine
Metabolism
Middle Aged
Mortality
Multivariate Analysis
National health insurance
Patient compliance
Patients
Population studies
Population-based studies
Questionnaires
Regression analysis
Regression models
Response rates
Risk Factors
Santé publique et épidémiologie
Self Report
Skill development
Social aspects
Social interactions
Studies
Substance abuse treatment
Surveys
Type 2 diabetes
Young Adult
title Medication adherence in type 2 diabetes: the ENTRED study 2007, a French Population-Based Study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T08%3A14%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Medication%20adherence%20in%20type%202%20diabetes:%20the%20ENTRED%20study%202007,%20a%20French%20Population-Based%20Study&rft.jtitle=PloS%20one&rft.au=Tiv,%20Michel&rft.date=2012-03-05&rft.volume=7&rft.issue=3&rft.spage=e32412&rft.epage=e32412&rft.pages=e32412-e32412&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0032412&rft_dat=%3Cgale_plos_%3EA477157209%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1323964555&rft_id=info:pmid/22403654&rft_galeid=A477157209&rft_doaj_id=oai_doaj_org_article_6e2c5ca4c7ba4d69af3990a26d3177d3&rfr_iscdi=true